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Background: Lower airway abnormalities are common in patients with primary ciliary dyskinesia (PCD), a pediatric
syndrome that results from structural or functional defects in motile cilia. Patients can suffer from recurrent bacterial
infection in the lung, bronchiectasis, and respiratory distress in addition to chronic sinusitis, otitis media, infertility,
and laterality defects. However, surprisingly little is known about the pulmonary phenotype of mouse models of
this disorder.
Results: The pulmonary phenotype of two mouse models of PCD, nm1054 and bgh, which lack Pcdp1 and Spef2,
respectively, was investigated by histological and immunohistochemical analysis. In addition, both models were
challenged with Streptococcus pneumoniae, a common respiratory pathogen found in the lungs of PCD patients.
Histopathological analyses reveal no detectable cellular, developmental, or inflammatory abnormalities in the lower
airway of either PCD model. However, exposure to S. pneumoniae results in a markedly enhanced inflammatory
response in both models. Based on analysis of inflammatory cells in bronchoalveolar lavage fluid and flow
cytometric analysis of cytokines in the lung, the bgh model shows a particularly dramatic lymphocytic response by
3 days post-infection compared to the nm1054 model or wild type animals.
Conclusions: Defects in ciliary motility result in a severe response to pulmonary infection. The PCD models nm1054
and bgh are distinct and clinically relevant models for future studies investigating the role of mucociliary clearance
in host defense.
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Streptococcus pneumoniae, an anaerobic, gram-positive
bacterium, is the primary cause of bacterial pneumonia
and a major cause of sinusitis, otitis media, and bacterial
meningitis [1-3]. Symptoms of pneumococcal pneumo-
nia commonly include a persistent cough, excess pro-
duction of sputum, shortness of breath, and fever, with
most patients also showing evidence of a pulmonary in-
filtrate [1,3]. Despite the effectiveness of antibiotics and
immunizations, pneumococcal pneumonia continues to* Correspondence: lance.lee@sanfordhealth.org
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2013result in respiratory failure, hospitalization, and mortal-
ity in many patients, particularly young children, the eld-
erly, and individuals with additional underlying medical
conditions [1,2,4]. It is estimated that over one million
childhood deaths are associated with pneumococcal
pneumonia each year [3].
The response to respiratory pathogens involves mucus
secretion, clearance by ciliary motility, and an inflamma-
tory response [5-7]. Because of the role of cilia in this re-
sponse, pulmonary disease is a major component of
primary ciliary dyskinesia (PCD), an autosomal recessive,
pediatric syndrome that results from defects in ciliary
and flagellar motility and is commonly characterized by
chronic upper and lower respiratory infection, otitis
media, male infertility, and situs inversus, as well as lessral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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tility [8-13]. Because mucociliary clearance is critical for
lung maintenance and host defense, PCD patients typic-
ally have a variety of pulmonary defects as early as the
neonatal period [5,14-18]. Several large or longitudinal
clinical studies analyzing pulmonary function and dis-
ease in diagnosed PCD patients found a variety of com-
mon conditions [19-33]. Patients typically suffered from
recurrent pneumonia, a chronic cough, excess sputum
production, and severe bronchiectasis. Neonatal respira-
tory distress was frequently reported in infants, while
airway obstruction, atelectases, and a progressive, irre-
versible decline in pulmonary function were commonly
seen in older patients. Bacteria were identified in the
sputum from most patients, with Haemophilus influen-
zae, Streptococcus pneumoniae, and Staphylococcus aur-
eus being the most common. Pseudomonas aeruginosa, a
pathogen commonly found in the lungs of cystic fibrosis
patients, was only rarely identified in PCD patients.
Despite the strong correlation of lower airway disease
with PCD in patients, there is a surprising paucity of
information about lung disease in mouse models of
PCD or the usefulness of those models for developing
improved therapies for lung disease. Although several
mouse models with PCD or PCD-related phenotypes
have been described [11,12], pulmonary defects have
only been reported in three. Studies involving lower air-
way disease are complicated in some models that exhibit
early lethality due to hydrocephalus or laterality defects,
but several other models have been described on genetic
backgrounds that are less susceptible to severe hydro-
cephalus and therefore live a longer lifespan [12]. Mice
lacking both sperm associated antigens 6 (Spag6) and
16 L (Spag16L), which have been shown to interact in
the cilium, have severe lower airway disease character-
ized by pneumonia, atelectases, and hemorrhage [34,35].
Despite the presence of other PCD phenotypes, respira-
tory abnormalities were not reported in mutants lacking
either individual protein [36,37], possibly due to the
functional relationship between the two proteins. Loss of
Spag17 also results in PCD, with homozygous mutants
exhibiting an accumulation of fluid in their lungs, dam-
age to the alveolar cells, and a failure to thrive [38]. Se-
vere lower airway disease was also observed in mice
lacking the Wnt inhibitor Chibby and is characterized by
abnormal lung pathology, reduced proliferation and dif-
ferentiation of respiratory epithelial cells, and an inability
to clear P. aeruginosa after infection [39,40]. While these
studies indicate that mouse models may be valuable
tools for better understanding and treating the array of
pulmonary phenotypes associated with PCD, they are
limited in number and have not yet explored the re-
sponse to the respiratory pathogens most commonly ob-
served in human PCD patients.PCD has been previously reported in the nm1054
and big giant head (bgh) mouse models and is character-
ized, in both cases, by hydrocephalus, male infertility,
and upper respiratory abnormalities [41,42]. The pheno-
types in the nm1054 and bgh models are caused by loss
of ciliary proteins primary ciliary dyskinesia protein 1
(Pcdp1) and sperm flagellar protein 2 (Spef2), respect-
ively [41,42]. The PCD phenotypes demonstrate that
both genes are required for proper ciliary function, al-
though mutations have not yet been identified in human
PCD patients. In the nm1054 mutant, there is a marked
accumulation of mucus in the upper airway [41], while
the bgh mutant has a similar accumulation of mucus ac-
companied by an infiltration of neutrophils [42], which
is indicative of an inflammatory response in the airway
[17,43]. The respiratory epithelial cilia have a normal
ultrastructure in both models [41,42]. However, the cil-
iary beat frequency (CBF) is decreased by approximately
25% in the nm1054 mouse and approximately 17% in
the bgh mouse [41,42], likely resulting in the inability to
clear mucus in the airway. Given these findings, it is ex-
pected that a defect in mucociliary clearance would also
affect the lower airway and predispose these models to
severe respiratory infection.
In this study, we conducted a comprehensive histo-
pathological analysis of the lungs of both the nm1054
and the bgh model. Despite the pathological findings in
the upper airway and the pulmonary abnormalities ob-
served in other PCD models, there are no major cellular,
developmental, or inflammatory abnormalities in the
lower airway of either the nm1054 or the bgh mutant. In
contrast, there is a markedly enhanced acute inflamma-
tory response in both models after infection with S.
pneumoniae, with the bgh model showing a particularly
dramatic lymphocytic response within 3 days of infec-
tion. These findings demonstrate that defects in ciliary
motility in both PCD mutants result in severe pulmon-
ary infection and establish clinically relevant models for




The nm1054 [41] and bgh [42] lines were maintained on
both the C57BL/6 J (B6) and 129S6/SvEvTac (129) back-
grounds as previously described. All phenotypic analyses
were performed on (B6x129)F1 animals at least 8 weeks
old. All procedures were approved by either the Sanford
Research/USD or the University of South Dakota Institu-
tional Animal Care and Use Committee.
Histology
Three wild type, three nm1054, and three bgh lungs were
inflated with 10% phosphate-buffered formalin using an
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were removed from the body cavity and immersion fixed
in 10% phosphate-buffered formalin. The fixed tissue was
embedded in paraffin wax on a Leica 300 ASP tissue pro-
cessor, serially sectioned through the airway, and stained
with hematoxylin and eosin on a Sakura Tissue-Tek auto-
mated stainer. Sections were analyzed qualitatively by light
microscopy on an Olympus IX71 microscope.
Immunohistochemistry
Sections from the three wild type, three nm1054, and
three bgh lungs used for histology were stained with
primary and secondary antibodies using the BenchMark
XT automated slide staining system (Ventana Medical
Systems, Inc.). The mouse acetylated tubulin antibody
(Sigma Aldrich) was used at 1:6,000 and incubated for
30 minutes at 37°C. The goat Clara cell secretory protein
(CCSP) (courtesy of Barry Stripp, Duke University Med-
ical Center, Durham, NC, USA) and rabbit prosurfactant
protein B (Chemicon) antibodies were used at 1:250 and
incubated for 1 hour at 37°C. The Syrian hamster T1α
glycoprotein 38 kD mucin-like antibody (Hybridoma
Bank) was used at 1:1,000 and incubated for 1 hour
at 37°C. All secondary antibodies were from Jackson
ImmunoResearch. Biotin SP-conjugated AffiniPure goat
anti-rabbit and goat anti-Syrian hamster secondary anti-
bodies were used at 1:1,000, and the Biotin SP-
conjugated AffiniPure donkey anti-mouse and donkey
anti-goat secondary antibodies were used at 1:500.
Staining was detected using the Ventana iView DAB kit,
and the slides were counterstained with hematoxylin
and qualitatively analyzed by light microscopy on an
Olympus IX71 microscope.
Alveolar chord length measurement
Images of lung sections from the three wild type, three
nm1054, and three bgh mice analyzed by histology above
were taken on a Nikon 90i microscope using a 10X ob-
jective and at a 1,600 × 1,200 resolution. Alveolar cord
length was measured as previously described using the
Image J software [44,45], and statistical significance was
determined using the Student’s t-test.
Bacterial infection
Mice anesthetized with isoflurane were infected with the
TIGR4 strain of S. pneumoniae (courtesy of Carlos Orihuela,
University of Texas Health Science Center, San Antonio,
TX, USA) by nasal instillation with a total of 5 ×
104 CFU in 10 μL inoculated into the left nostril. Body
weights were collected for all mice prior to inoculation
and at the time of death. Nasal carriage was assessed in
surviving mice prior to euthanasia at 1, 2, or 3 days
post-infection by instilling 25 μL of phosphate buffered
saline into the left nostril, recovering, serially diluting,and plating on 10% sheep red blood cell agar [46]. Lung
titer was assessed following euthanasia at 1, 2, or 3 days
post-infection by homogenizing the left lung with an
IKA T10 Basic S1 disperser, serially diluting the hom-
ogenate, and plating on 10% sheep red blood cell agar as
previously described. Statistical significance was deter-
mined using the Student’s t-test. The following numbers
of mice were analyzed for nasal carriage and lung titer:
on day 1, four wild type, four nm1054, and four bgh; at
day 2, four wild type, four nm1054, and eight bgh; and
at day 3, four wild type, four nm1054, and eight bgh.
Bronchoalveolar lavage
Bronchoalveolar lavage fluid was isolated from four unin-
fected wild type, four uninfected nm1054, and three unin-
fected bgh mice, as well as three wild type, three nm1054,
and three bgh mice 2 and 3 days after infection with S.
pneumoniae. Lungs were inflated with 1 mL of Hank’s Bal-
anced Salt Solution (HBSS) media containing 5 mM EDTA
using the inflation procedure described above, and the fluid
was collected through the same catheter using a separate
syringe. Inflation and collection was repeated six times.
Lavage fluid was centrifuged at 400 × g for ten minutes at
4°C. The supernatant was removed, and the cells were
pooled and resuspended in 200 μL of HBSS media contain-
ing 5 mM EDTA. The cells were loaded onto slides and
spun in a StatSpin Cytofuge 2 cytocentrifuge (Iris Sample
Processing, Inc.) at 600 rpm for 6 minutes. The slides were
fixed with methanol, stained with the Camco differential
stain kit, and visualized on an Olympus IX71 microscope.
Cytokine profiling
Cytokines were analyzed in lungs from uninfected mice
(day 0) and 1, 2, or 3 days after infection with S. pneumo-
niae. Right lungs were homogenized as described above
and centrifuged at 5,000 rpm for 1 minute. Cytokines in
the supernatant were analyzed using the Cytometric Bead
Array Mouse Th1/Th2/Th17 Cytokine Kit (BD Biosci-
ences) and an Accuri C6 flow cytometer (BD Biosciences)
following manufacturer’s instructions. Cytokine levels were
normalized to internal standards, and a standard curve was
generated using the GraphPad Prism 4 software. Statistical
significance was determined using the Student’s t-test. The
following numbers of mice were analyzed for cytokines: on
day 0, four wild type, four nm1054, and four bgh; on day 1,
four wild type, four nm1054, and four bgh; on day 2, four
wild type, four nm1054, and eight bgh; and on day 3, four
wild type, four nm1054, and eight bgh.
Results
Absence of lower airway pathology in nm1054 and bgh lungs
Because pulmonary abnormalities are common in pa-
tients with PCD, we investigated the lung phenotype in
both the nm1054 and bgh mutants. Histological analysis
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or any major damage to tissue structure in either model
(Figure 1A–C). Higher magnification images of the epi-
thelia lining the airway demonstrate that the epithelial
cilia are intact in both mutants (Figure 1D–F). To con-
firm these histological findings, a more detailed analysis
of tissue architecture was enabled by immunohistochem-
ical analysis of markers specific to airway cell types.
Acetylated tubulin, which is expressed in the ciliated
epithelial cells lining the airway, is properly expressed
and localized to the cilia in both mutants (Figure 2A–C),
confirming the normal appearance of respiratory epithe-
lial cilia. Expression of CCSP, a marker of the Clara cells
that also line the airway, shows a normal appearance and
distribution of this epithelial cell type (Figure 2D–F). The
alveolar epithelial cells were detected with antibodies to
T1α and Prosurfactant protein B, which are markers for
the type I and type II alveolar cells, respectively. Proper
expression was detected for both T1α (Figure 2G–I) and
Prosurfactant protein B (Figure 2J–L) in both PCD mu-
tants, indicating that there are no significant abnormalities
in the alveolar cell types. In addition, measurements of
alveolar chord length showed no significant differences
in the alveolar airspace in either the nm1054 or the bgh
lung (Additional file 1). Prosurfactant protein B is also
expressed in the Clara cells, and normal expression in
both mutants confirms the presence and normal distribu-
tion of this cell type. Proper expression of these cell-
specific markers indicates that there are no developmental
defects or secondary damage to the airway surface due to
defective mucociliary clearance.
Because previous histological analysis of the maxillary
sinus cavity of bgh mutants indicated the presence of
an inflammatory response [42], we investigated whether
an inflammatory response was active in the lower airway
of both models. Presence or absence of inflammatory
cells in the lower airway of nm1054 and bgh mutants
was assessed in bronchoalveolar lavage (BAL) fluid. TheFigure 1 Histopathology of mutant lungs. Sections of wild type (A,D), n
an absence of major defects in either mutant. High magnification images (
mutants. Sections are stained with hematoxylin and eosin. Scale bars repreinflammatory cells in wild type lungs consist primarily
of resident and circulatory macrophages (Figure 3A;
Table 1). This is indicative of a healthy respiratory sys-
tem, where macrophages typically comprise 95% of in-
flammatory cells [43]. Consistent with an absence of
abnormal pathology in the mutant lungs, only resident
alveolar macrophages were detected in BAL fluid from
nm1054 (Figure 3B; Table 1) and bgh (Figure 3C; Table 1)
animals. There was no evidence of polymorphonuclear
leukocytes or lymphocytes in the airway of either mu-
tant. These findings suggest that, despite evidence of
mucus accumulation and an inflammatory response in
the upper airway, a defect in respiratory epithelial ciliary
motility does not result in a detectable phenotype in the
lungs of either the nm1054 or the bgh mutant.
Response to Streptococcus pneumoniae infection in
nm1054 and bgh mutants
The surprising absence of a pulmonary phenotype in
nm1054 and bgh mutants could be due to a milder de-
fect in mucociliary clearance in the lower airway. It is
also possible that the lower airway of these models may
be impervious to any significant damage in a clean envir-
onment without a respiratory challenge. To investigate
whether nm1054 and bgh mutants might exhibit a lower
airway phenotype in response to a challenge, we infected
both models with S. pneumoniae, a common respiratory
pathogen seen in the airway of human PCD patients.
Infection appeared to result in increased morbidity in
both mutants, with one nm1054 and one bgh mouse
dying approximately 3 days after infection. Body weights
for infected wild type, nm1054, and bgh mice remained
largely unchanged for mice euthanized for analysis of in-
flammation up to 3 days post-infection (Additional file 2).
However, those mice that died as a result of infection ex-
hibited weight loss and wasting prior to death, with the
nm1054 mouse weighing approximately 76% of its initial
weight prior to infection and the bgh mouse weighingm1054 (B,E), and bgh (C,F) lungs through the major airway showing
D–F) show that cilia are present on the epithelial surface of both
sent either 500 (A–C) or 50 (D–F) μm.
Figure 2 Absence of cellular defects in mutant lungs. Immunohistochemical analysis of cell-specific markers in wild type (A,D,G,J), nm1054
(B,E,H,K), and bgh (C,F,I,L) lungs. (A–C) Acetylated tubulin, a marker of epithelial cilia showing a normal appearance and distribution of cilia in
both mutants. (D–F) CCSP, a marker of Clara cells. (G–I) T1α, a marker of alveolar type I cells. (J–L) Prosurfactant protein B, a marker of alveolar
type II cells and Clara cells. Arrowheads indicate the stained epithelial (A–C), Clara (D–F), alveolar type I (G–I), and alveolar type II (J–L) cells.
Scale bars represent 100 μm.
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stantial decline in health after infection. In contrast, none
of the infected wild type controls exhibited any sign of ab-
normal health or expired prior to euthanasia.
To investigate the effect of ciliary dysfunction, wild
type, nm1054, and bgh mice were analyzed for an acute
inflammatory response during the 3 days after infection.
During this time, there were no significant changes in
bacterial nasal carriage or lung titer (Additional file 3),
suggesting an inability to clear the pathogen within this
period. Analysis of cells in BAL fluid on days 2 and 3
after infection demonstrated a clear immune response in
wild type, nm1054, and bgh mice. Infected wild type
mice exhibited a shift from activated resident macro-
phages on day 2 to activated infiltrating macrophages
differentiated from circulatory monocytes on day 3,when the activated infiltrating macrophage population
comprised approximately 78% of the cells in the BAL
fluid (Figure 4D,G; Table 1). In contrast to the wild type
response, the nm1054 BAL fluid shows a substantial in-
crease in the number of activated macrophages and T
lymphocytes on day 2 (Figure 4E; Table 1). By day 3,
there is almost an equivalent presence of activated mac-
rophages (53%) and T lymphocytes (42%) (Figure 4H;
Table 1), demonstrating an enhanced lymphocytic re-
sponse to S. pneumoniae infection relative to wild type.
The most dramatic response to bacterial challenge was
observed in bgh lungs. As in the nm1054 mutant, day 2
shows a shift to activated macrophage and infiltrating T
lymphocyte populations (Figure 4F; Table 1). By day 3,
however, T lymphocytes comprise approximately 82% of
the inflammatory cell population (Figure 4I; Table 1).
Figure 3 Inflammatory cells in mutant lungs. Representative images of inflammatory cells in BAL fluid from wild type (A,D,G), nm1054 (B,E,H),
and bgh (C,F,I) lungs. BAL fluid was analyzed in uninfected animals (A–C) and either 2 days (D–F) or 3 days (G–I) after infection with S.
pneumoniae. Examples of lymphocytes in infected lungs are indicated by arrowheads. Cells were stained with the Camco Stain Pak differential
staining kit. Scale bars represent 50 μm.
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larly aggressive immune response in bgh lungs compared
to wild type or nm1054 mice. Several other cell types, in-
cluding neutrophils, eosinophils, and dendritic cells, were
observed in infected lungs at low frequency, but these
numbers were negligible compared to the infiltration of
macrophages and T lymphocytes.Table 1 Inflammatory cells in BAL fluid
Mouse line Day post-infection Total number of
cells counted m
Wild type Uninfected 272
Wild type 2 441







Cell types were counted in pooled representative fields from three mice in each gro
are shown. Percentages less than five are indicated by a dash, and only cell types rThe acute inflammatory response observed in BAL fluid
is supported by flow cytometric analyses of cytokines in
lung lysates, which were performed in uninfected lungs
and at days 1, 2, and 3 after infection with S. pneumoniae
(Figure 4). The cytokine profiles show a marked response
to infection in the bgh mutant. Early infection cytokines














up in a blinded manner, and approximate percentages of the total number
epresenting at least 5% of the total cells are included.
Figure 4 (See legend on next page.)
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Figure 4 Enhanced cytokine levels in response to S. pneumoniae infection. Levels of IL-6 (A), TNF (B), IL-2 (C), IFNγ (D), IL-4 (E), IL-17 (F),
and IL-10 (G) were measured in wild type, nm1054, and bgh lung homogenates by flow cytometry using a cytometric bead array mouse Th1/
Th2/Th17 cytokine kit. Mice were infected with S. pneumoniae on day 0, and cytokine levels were measured on days 0, 1, 2, and 3. Cytokine levels
are normalized to internal standards. Statistical significance relative to wild type (P <0.05) is indicated by an asterisk.
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tically significant increase (P <0.05 by Student’s t-test) in
the bgh lung as early as day 1 (Figure 4A,B), indicating the
onset of an inflammatory response. Both cytokines
remained at either significantly higher or elevated levels
through day 3 relative to wild type. Lack of statistical sig-
nificance is likely due to typical variation in immune re-
sponse within the mouse sampling. In addition, there is
either an upward trend or a significant increase in the
level of IL-2, interferon gamma (IFNγ), IL-4, and IL-17, all
of which are indicators of T lymphocyte activation, by
days 2 and 3 (Figure 4C-F). The elevated levels of lympho-
cytic cytokines are consistent with the aggressive infiltra-
tion of lymphocytes observed in bgh BAL fluid (Figure 3,
Table 1). Finally, an increase in the level of anti-
inflammatory cytokine IL-10, which is produced by acti-
vated T regulatory cells, is observed on days 1 through 3
(Figure 4G). In contrast to the cytokine profile of bgh
lungs, a less striking response is observed in nm1054
lungs. By day 3, a significant increase was only observed
for IL-6 (Figure 4A), which is indicative of an early macro-
phagic response, and IL-2 (Figure 4C), which is consistent
with the mild lymphocytic response observed in the
nm1054 BAL fluid (Figure 3, Table 1).
Discussion
Although chronic lung disease is commonly associated
with PCD in human patients, there are no significant
histopathological defects in the lungs of mice lacking ei-
ther ciliary protein Pcdp1 or Spef2, despite the presence of
upper airway abnormalities, male infertility, hydroceph-
alus, and a decrease in ciliary motility [41,42]. However,
infection with S. pneumoniae results in an enhanced acute
inflammatory response in both PCD models. It is likely
that the defects in ciliary motility result in perturbed
mucociliary clearance of the pathogen, which leads to the
enhanced immune response. Persistent bacterial infection
is indicated by unchanged levels in nasal carriage and lung
titer over 3 days after inoculation with S. pneumoniae.
The absence of a detectable phenotype in uninfected
mutant lungs may in part be due to the housing of these
animals in a clean, pathogen-free environment void of
any pulmonary challenges. In this environment, the in-
flammation previously observed in the upper airway of
the bgh mutant may be sufficient to protect the lower
airway from any significant pathology [42]. Alternatively,
absence of an unchallenged pulmonary phenotype couldresult from a milder defect in mucociliary clearance in
the lower airway that is related to the functions of Pcdp1
and Spef2, which is supported by the presence of lung
disease in unchallenged mice lacking other ciliary pro-
teins, such as Spag17 or both Spag6 and Spag16L
[35,38]. Relatively little is known about the function of
either Pcdp1 or Spef2. The Chlamydomonas reinhardtii
homolog of Pcdp1, FAP221, was shown to associate with
a protein complex that localizes to the central pair ap-
paratus of the cilium and regulates motility in a calcium-
dependent pathway [47]. Spef2 was shown to associate
with intraflagellar transport protein IFT20 in the testis
[48], and its likely C. reinhardtii homolog also associates
with the central pair apparatus [49]. Absence of laterality
defects in both models is likely due to the localization
and function of these proteins at the central pair appar-
atus, which is absent in the nodal cilia required for em-
bryonic left-right patterning [41,42]. It is unknown
whether Pcdp1 and Spef2 have related functions in the
central pair apparatus, and the mechanisms by which
these two proteins regulate mammalian ciliary function
remains elusive.
Microscopic analysis of inflammatory cells in the airway
and flow cytometric analysis of cytokine levels are consist-
ent with an enhanced acute inflammatory response,
particularly in the bgh mutant. The typical response to
S. pneumoniae infection involves initial clearance by acti-
vated resident macrophages, followed by recruitment of
neutrophils, monocytes, and lymphocytes from the blood-
stream [2,4,43,50]. Kadioglu et al. showed that, in mice,
the number of neutrophils and infiltrating macrophages
increases within the first 12 to 24 hours after S. pneumo-
niae infection, with lymphocytes infiltrating by 48 hours
post-infection [51]. Both the nm1054 and the bgh mutant
show a shift toward an activated macrophage and infiltrat-
ing lymphocytic response by the second day after infec-
tion. A milder response is seen in infected wild type
animals, where the shift to macrophage activation is not
evident until day 3, and the lymphocytic recruitment re-
mains relatively low. By day 3, the bgh animals exhibit a
dramatic lymphocytic response, with T lymphocytes com-
prising more than 80% of the cells isolated from the BAL
fluid. A small number of neutrophils were observed in the
BAL fluid from each mutant, but this was lower than 5%
at all time points. While it is possible that the response in
these PCD mutants is primarily macrophagic and lympho-
cytic, it is more likely that there is an early and brief
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phils drops dramatically and is replaced by lymphocytes
and macrophages by day 2 post-infection.
The acute inflammatory response observed in BAL fluid
after infection is supported by quantification of cytokine
levels in the lung. There is a statistically significant in-
crease in IL-6 by day 1 in the bgh mutant and by day 3 in
the nm1054 mutant compared to wild type. IL-6, which is
secreted by resident macrophages and plays a role in both
neutrophil recruitment and T cell differentiation, is up-
regulated in multiple pulmonary inflammatory diseases
and is a consistent marker of early inflammation [4,52,53].
In addition, mice lacking IL-6 have an impaired immune
response to S. pneumoniae infection, with mutants dis-
playing a higher lung bacterial titer, increased levels of
pro-inflammatory and anti-inflammatory cytokines, and
increased morbidity [54], further demonstrating that IL-6
plays an important role in early host defense. Therefore,
the high levels of IL-6 in nm1054 and bgh lungs indicate
the onset of a more persistent inflammatory response in
both PCD mutants than infected wild type animals. In-
creased secretion of TNF, which is secreted by macro-
phages and, along with IL-6, stimulates production of
several other cytokines, is also associated with an early in-
flammatory response [55]. TNF levels following infection
are only increased in the bgh mutant, further suggesting
that the immune response is more severe in the bgh mu-
tant than the nm1054 mutant. The increase in TNF levels
in the bgh lung is statistically significant on day 1 but loses
significance thereafter, likely due to variability observed in
TNF levels in the sampling of mutant mice.
IL-2 plays a critical role in driving the lymphocytic re-
sponse [56]. Consistent with an increased number of lym-
phocytes in BAL fluid from both PCD mutants, there is a
statistically significant increase in IL-2 levels in the bgh
mutant by day 2 and in the nm1054 mutant by day 3 rela-
tive to infected wild type animals. IL-2 is secreted by naïve
T cells and promotes their differentiation into Th1 helper
cells, Th2 helper cells, Th17 helper cells, and T regulatory
cells, which in turn secrete IFNγ, IL-4, IL-17, and the anti-
inflammatory cytokine IL-10, respectively [56,57]. A statis-
tically significant increase in IFNγ, IL-4, IL-17, and IL-10
levels was observed in bgh mutants. The increase in IL-10
lost its statistical significance after day 1, but like TNF, this
is likely due to variability in the sample population. In
contrast, there is no statistically significant change in the
levels of any of these T helper or T regulatory cytokines in
the nm1054 lung relative to the wild type, providing fur-
ther evidence that the bgh mice have a more severe
lymphocytic response to bacterial infection.
Increases in lymphocytic cytokines in the bgh lung are
particularly important given their critical roles in the
lymphocytic response. IL-17, which has a pro-inflammatory
function in further recruitment of circulatory macrophagesand neutrophils, is typically elevated in patients with a var-
iety of pulmonary inflammatory diseases [58,59], and mice
lacking the IL-17 receptor A show an enhanced susceptibil-
ity to Klebsiella pneumoniae infection and increased mor-
bidity [60]. To prevent excessive damage to the lung, the
anti-inflammatory cytokine IL-10, which is secreted by T
regulatory cells, plays a critical role in mediating the
lymphocytic response by inhibiting naïve T cells, Th1 cells,
and Th2 cells [4,61-63]. This role was demonstrated in
mice inoculated with both S. pneumoniae and IL-10, which
resulted in a higher bacterial titer, decreased levels of pro-
inflammatory cytokines, and increased morbidity [64],
while infection with Aspergillus fumigatus in mice lacking
IL-10 results in an enhanced inflammatory response and
higher levels of pro-inflammatory cytokines in the airway
[63]. There is an upward trend in IL-10 levels in bgh mice
relative to wild type controls, and despite a lack of stat-
istical significance, these increases are greater than
those observed for the Th1, Th2, and Th17 cytokines. This
finding suggests that there may be an activation of the
anti-inflammatory response to mitigate damage to the
lung. Further analyses are required to fully determine the
extent of tissue damage in mutant lungs over the course
of infection and the potential interventions that can be
used to limit this damage in PCD patients.Conclusions
The findings in this study establish that mice lacking either
Pcdp1 or Spef2 are distinct, clinically relevant models with
an enhanced lymphocytic response to pulmonary infection
with S. pneumoniae, a common respiratory pathogen in
patients with PCD. This is particularly significant given
that the pulmonary immune response to S. pneumoniae
has not been previously investigated in murine models of
PCD, and it strongly suggests that further research may be
necessary with additional bacterial, viral, and environmen-
tal challenges. Future analyses of inflammatory response
beyond the acute phase of infection may provide additional
evidence of compromised pathogen clearance in these
models. The effect of this compromise on pulmonary func-
tion, mortality, and susceptibility to infection also warrants
further study. Differences in the severity of response to in-
fection in the nm1054 and bgh mutants may be due to dif-
ferences in Pcdp1 and Spef2 protein function that could
have differential effects on mucociliary clearance. Elucidat-
ing the biochemical mechanism by which these proteins
regulate ciliary motility will ultimately uncover their roles
in pathogen clearance and host defense.Additional files
: Mean alveolar chord length in mutant lungs.
Alveolar chord lengths were measured in sections of wild type, nm1054,
Additional file 1
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http://www.ciliajournal.com/content/2/1/18and bgh lungs. Lengths are not statistically different between mutant and
wild type.
: Body weights after infection with S. pneumoniae.
Body weights were measured for wild type (A), nm1054 (B), and bgh (C)
mice prior to infection (Day 0) and on the day of euthanasia and analysis
(Day 1, Day 2, or Day 3). To normalize the data, weight values are
presented as percentage of initial weight (Day 0) on the day of analysis.
Body weights are largely unaffected for all mice euthanized for analysis.
: Levels of S. pneumoniae in the mutant respiratory
systems. Bacterial counts were determined in the nose (A) and lung
homogenates (B) of wild type, nm1054, and bgh animals on days 1, 2,
and 3 after infection with S. pneumoniae. Counts are not statistically
different between mutant and wild type.
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